유방암 환자에서 근거기반의 림프부종 예방관리
Received: Nov 03, 2019; Accepted: Nov 15, 2019
Published Online: Nov 30, 2019
Abatract
Breast-cancer related arm-lymphedema (BCRL) is one of the most common and severe side effects of breast cancer treatment and results in a negative impact on the quality of life. High body mass index, type of axillary surgery, number of excised axillary lymph nodes, types and cycles of chemotherapy, and extent of radiotherapy have been reported to increase risk of BCRL. Almost of BCRL has been reported to occur during the first 2-3 years after surgery. In the life styles, air travel, ipsilateral arm blood pressure measurements, and skin/veno puncture have had no effect of BCRL. Extreme temperature such as sauna, and cellulitis would increase risk of BCRL. Clinicians need to educate their patients with evidence-based precaution guideline.
Metrics
QR Code of this Article:
Related Articles
Analysis of Predictive Factors for Arm Lymphedema Following Salvage Radiotherapy for Patients with Recurrent Breast Cancer
Clin. Lymphology Lymphedema 2025;10(2):53-62.
Translation and Validation of the Korean Version of Lymphedema Quality of Life Tool (LYMQoL) in Patients with Breast Cancer Related Lymphedema
Clin. Lymphology Lymphedema 2023;8(2):50-57.
Validation of Korean Version of ‘Questionnaire to Characterize Lymphedema in Women Treated for Breast Cancer’
Clin. Lymphology Lymphedema 2017;2(1):16-21.
Breast Cancer Related Lymphedema
Clin. Lymphology Lymphedema 2016;1(1):2-6.
A Prospective Surveillance Model of Breast Cancer-Related Lymphedema
Clin. Lymphology Lymphedema 2016;1(1):33-37.
